Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
SLAB · Nasdaq · United States · Semiconductors & Related Devices
In shortSILICON LABORATORIES INC. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -9.0% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -8.3% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -6.0% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | – | n/a |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 4.69× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | – | n/a |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -72.35× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 11.34 | 100/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 8.4% | 54/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 3 of 5 | 50/100 |
Weight in the score: 20%
| Profitable years (last 5) | 2 of 5 | 40/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 35.0% | 0/100 |
| Operating margin volatility | 14.4% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -8.5% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2026 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY22 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Revenue | 721 | 1,024 | 782 | 584 | 785 |
| Cost of revenue | 295 | 382 | 322 | 272 | 328 |
| Gross profit | 425 | 643 | 461 | 312 | 457 |
| Research & development | 273 | 332 | 338 | 332 | 353 |
| Selling, general & admin | 185 | 191 | 147 | 145 | 174 |
| Operating income | (33) | 119 | (24) | (165) | (71) |
| Interest expense | 31 | 6.7 | 5.6 | 1.3 | 1 |
| Pre-tax income | (44) | 130 | (27) | (155) | (58) |
| Income tax | 13 | 38 | 7.9 | 36 | 7 |
| Net income | 2,117 | 91 | (35) | (191) | (65) |
| Diluted EPS | $47.78 | $2.54 | −$1.09 | −$5.93 | −$1.98 |
| Diluted shares (millions) | 44 | 36 | 32 | 32 | 33 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of SILICON LABORATORIES INC. are included in the Investor plan. Try free for 7 days →
11.34 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jul 4, 2026 · Data updated Aug 11, 2026